Implications of the emerging SARS-CoV-2 variant VOC 202012/01
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Implications of the emerging SARS-CoV-2 variant VOC 202012/01

Filetype[PDF-114.30 KB]


English
Details Supporting Files You May Also Like

Details:

  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
  • Description:
    Updated Dec. 22, 2020

    A new variant strain of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in London and southeast England. Based on these mutations, this variant strain has been predicted to potentially be more rapidly transmissible than other circulating strains of SARS-CoV-2. Although a variant may predominate in a geographic area, that fact alone does not mean that the variant is more infectious. Scientists are working to learn more about this variant to better understand how easily it might be transmitted and whether currently authorized vaccines will protect people against it. At this time, there is no evidence that this variant causes more severe illness or increased risk of death. Information regarding the virologic, epidemiologic, and clinical characteristics of the variant are rapidly emerging. CDC, in collaboration with other public health agencies, is monitoring the situation closely. CDC will communicate new information as it becomes available.

  • Content Notes:
    Executive summary -- Does this variant have a name? -- Why has this variant been in the news recently? -- Why has this variant emerged in the UK? -- Have we seen this variant in the United States? -- What do we know already about variants containing N501Y? -- What about the other mutations in this variant of SARS-CoV-2? -- What implications could the emergence of new variants have? -- Is this new variant related to the newly emergent variant in South Africa? -- What is CDC doing to track emerging variants of SARS-CoV-2?
  • Subjects:
  • Series:
    Scientific Brief
  • Document Type:
    Text
  • Genre:
    Webpage
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov